Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. Sep-Oct 2017;23(5):265-267.
doi: 10.4103/sjg.SJG_292_17.

Failure of Optimized Dual Proton Pump Inhibitor Amoxicillin Therapy: What Now?

Affiliations
Free PMC article
Editorial

Failure of Optimized Dual Proton Pump Inhibitor Amoxicillin Therapy: What Now?

David Y Graham et al. Saudi J Gastroenterol. .
Free PMC article

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

Cited by 5 articles

References

    1. Unge P, Gad A, Gnarpe H, Olsson J. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol Suppl. 1989;167:49–54. - PubMed
    1. Dore MP, Lu H, Graham DY. Role of bismuth in improving Helicobacter pylori eradication with triple therapy. Gut. 2016;65:870–8. - PubMed
    1. van der Hulst RW, Keller JJ, Rauws EA, Tytgat GN. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter. 1996;1:6–19. - PubMed
    1. Bayerdorffer E, Miehlke S, Mannes GA, Sommer A, Hochter W, Weingart J, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology. 1995;108:1412–7. - PubMed
    1. Fleischmann R, Demharter R, Barnert J, Fuger K, Wienbeck M, Busch R. Eradication of Helicobacter pylori in peptic ulcer disease with amoxicillin, 2.0 g, and omeprazole, 80 or 120 mg: A prospective randomized trial. Eur J Gastroenterol Hepatol. 1997;9:593–8. - PubMed

Publication types

MeSH terms

Feedback